Correlation Between Nurix Therapeutics and Gossamer Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Nurix Therapeutics and Gossamer Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nurix Therapeutics and Gossamer Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nurix Therapeutics and Gossamer Bio, you can compare the effects of market volatilities on Nurix Therapeutics and Gossamer Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nurix Therapeutics with a short position of Gossamer Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nurix Therapeutics and Gossamer Bio.

Diversification Opportunities for Nurix Therapeutics and Gossamer Bio

0.22
  Correlation Coefficient

Modest diversification

The 3 months correlation between Nurix and Gossamer is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding Nurix Therapeutics and Gossamer Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gossamer Bio and Nurix Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nurix Therapeutics are associated (or correlated) with Gossamer Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gossamer Bio has no effect on the direction of Nurix Therapeutics i.e., Nurix Therapeutics and Gossamer Bio go up and down completely randomly.

Pair Corralation between Nurix Therapeutics and Gossamer Bio

Given the investment horizon of 90 days Nurix Therapeutics is expected to under-perform the Gossamer Bio. But the stock apears to be less risky and, when comparing its historical volatility, Nurix Therapeutics is 1.51 times less risky than Gossamer Bio. The stock trades about -0.14 of its potential returns per unit of risk. The Gossamer Bio is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  88.00  in Gossamer Bio on October 6, 2024 and sell it today you would earn a total of  14.00  from holding Gossamer Bio or generate 15.91% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Nurix Therapeutics  vs.  Gossamer Bio

 Performance 
       Timeline  
Nurix Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Nurix Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong forward indicators, Nurix Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Gossamer Bio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Gossamer Bio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Gossamer Bio is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Nurix Therapeutics and Gossamer Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Nurix Therapeutics and Gossamer Bio

The main advantage of trading using opposite Nurix Therapeutics and Gossamer Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nurix Therapeutics position performs unexpectedly, Gossamer Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gossamer Bio will offset losses from the drop in Gossamer Bio's long position.
The idea behind Nurix Therapeutics and Gossamer Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges